Evidence map›Paper›PMID 41768871›Full record

ArticleMetabolism open2026

Evaluation of the anti-hyperglycemic and anti-dyslipidemic potential of the hydroethanolic extract of

Pradeep Singh, Garima Mishra

Erratum issuedAbstract read
In one paragraph

Article in Metabolism open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Pradeep SinghPharmaceutical Chemistry Unit, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Garima MishraPharmaceutical Chemistry Unit, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Diabetes is a chronic metabolic disorder that affects approximately 537 million people worldwide. Modern diabetic therapies include adverse effects and are expensive. Scientists are often exploring affordable natural treatments with little or no side effects. Objective: In this experimental work, the hydroethanolic extract of Methods: Diabetes was induced in Wistar rats using an intraperitoneal injection of STZ (60 mg/kg) just 15 min after injecting NA (120 mg/kg). Glibenclamide (10 mg/kg) as a standard and hydroethanolic extract (250 and 500 mg/kg) were used for the treatment of diabetic rats. Throughout the study (21 days), normal and diabetic control animals were given only normal saline (5 mL/kg, p.o). Results: The findings revealed that hydroethanolic extract did not have any significant hypoglycemic activity but had a significant effect ( Conclusion: Conclusively, results from our study on

Indexed as

Blood glucose levelBody weightLipid profileLiver enzymesOral glucose toleranceType-2 diabetes mellitusβ-cells

Identifiers

PMID41768871
PMCPMC12945583

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.